Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide-Reference-Cited by-同舟云学术

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide

Published:2011-04-30 Issue:1 Volume:91 Page:89-92
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Palladini Giovanni,Russo Paola,Foli Andrea,Milani Paolo,Lavatelli Francesca,Obici Laura,Nuvolone Mario,Brugnatelli Silvia,Invernizzi Rosangela,Merlini Giampaolo

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-011-1244-x.pdf

Reference13 articles.

1. Merlini G, Stone M (2006) Dangerous small B-cell clones. Blood 108:2520–2530

2. Palladini G, Lavatelli F, Russo P et al (2006) Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood 107:3854–3858

3. Palladini G, Merlini G (2011) Transplantation vs. conventional-dose therapy for amyloidosis. Curr Opin Oncol 23:214–220

4. Dispenzieri A, Lacy M, Zeldenrust S et al (2007) The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood 109:465–470

5. Sanchorawala V, Wright D, Rosenzweig M et al (2007) Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood 109:492–496

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab;Current Oncology Reports;2024-06-19

2. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment;American Journal of Hematology;2023-12-14

3. A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment;Current Problems in Cardiology;2022-12

4. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment;American Journal of Hematology;2022-04-25

5. Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation;Blood Cancer Journal;2022-04-11